Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Study of LDL-c Lowering With Evolocumab: Observational Follow-up After the FOURIER OUTCOMES Trial.

NCT04128475 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT04128475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04128475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Study of LDL-c Lowering With Evolocumab: Observational Follow-up After the FOURIER OUTCOMES Trial.
Lead sponsor
University of Sydney
Phase
Observational
Overall status
Terminated
Start date
February 5, 2020
Completion date
April 26, 2021
Enrollment
1,137 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, cardiovascular morbidity, coronary heart disease, low-density-lipoprotein-type